A novel risk-scoring system conducing to chemotherapy decision for patients with pancreatic ductal adenocarcinoma after pancreatectomy

Background: Chemotherapy is suggested to use in all stages of pancreatic cancer. Is it reasonable to recommend chemotherapy for all PDAC patients? It is necessary to distinguish low-risk PDAC patients underwent pancreatectomy, who may not lose survival time due to missed chemotherapy and not need to...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Cancer
Hauptverfasser: Li, Yuqiang, Tian, Mengxiang, Zhou, Yuan, Tan, Fengbo, Liu, Wenxue, Zhao, Lilan, Perez, Daniel, Song, Xiangping, Wang, Dan, Nitschke, Christine, Pei, Qian, Güngör, Cenap
Format: Artigo
Sprache:Inglês
Veröffentlicht: Ivyspring International Publisher 2021
Schlagworte:
Research Paper
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8176415/
https://ncbi.nlm.nih.gov/pubmed/34093844
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.57768
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge